SEC Form 4 · accession 0001209191-17-055362
Intra-Cellular Therapies, Inc. · ITCI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
ALAFI CAPITAL CO LLC
10% Owner
Period of report
Oct 2, 2017
Accepted (ET)
Oct 3, 2017 · 6:08 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001567514
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Oct 2, 2017 | P | 258,065 | $15.50 | A | 3,953,270 | D |
Table II — derivative securities
No Table II lines on this filing.